Nanping Luyan Pharmaceutical Co., Ltd. announced that it will receive CNY 38 million in equity round of funding on October 27, 2021. The transaction will include participation from existing investor Luyan Pharma Co.,Ltd. Upon closing, the registered capital of the company will increase from CNY 12 million to CNY 50 million. The transaction has been approved in the seventh meeting of the fifth board of directors of the investor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.75 CNY | -1.80% | -3.42% | -2.67% |
04-15 | Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | Luyan Pharma Co.,Ltd. Announces Board Appointments | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.67% | 478M | |
+20.53% | 72.45B | |
-4.71% | 23.46B | |
+4.89% | 8.59B | |
+7.11% | 8.35B | |
-23.73% | 7.88B | |
+13.92% | 5.21B | |
-0.59% | 4.11B | |
+7.85% | 4.09B | |
+20.65% | 3.6B |
- Stock Market
- Equities
- 002788 Stock
- News Luyan Pharma Co.,Ltd.
- Nanping Luyan Pharmaceutical Co., Ltd. announced that it expects to receive CNY 38 million in funding from Luyan Pharma Co.,Ltd.